King Pharmaceuticals Revenue and Competitors

King, an S&P 500 Index company, is a vertically integrated branded pharmaceutical company that develops, manufactures and markets therapies and technologies primarily in specialty-driven markets including neuroscience, hospital and acute care medicines.\r\n\r\nKing’s business model offers the best qualities of a big and small company in one fully integrated pharmaceutical company. Our size enables us to build close personal relationships with the medical community and flexible collaborative partnerships with other pharmaceutical companies. Fully integrated resources in scientific and technical operations, coupled with a fully aligned sales force, enable us to move quickly to capitalize on scientific advances and bring innovative medicines and technologies to market. These strategic competencies, combined with dynamic executive leadership, strategic discipline and financial strength, have established King as a leading specialty pharmaceutical company.